Tag: Todd Fehniger December 16, 2024 $10.8 million grant supports cutting-edge leukemia researchNIH renews prestigious program for blood cancer research at WashU Medicine.News Release November 22, 2024 World leaders in ending blood cancerThe Siteman Blood Cancer Center, which brings together the multidisciplinary expertise of WashU Medicine physicians, has long been at the forefront of transforming care. .Outlook Magazine May 10, 2024 $5 million grant supports innovative immunotherapies against blood cancersLeukemia & Lymphoma Society supports trials in cell-based immunotherapies, cancer vaccines.News Release June 13, 2022 3 physician-scientists named Dean’s ScholarsProgram helps doctors pursue basic science research.Medical Campus & Community December 10, 2021 For children, young adults with recurrent AML, immunotherapy shows promiseNatural killer cells could help young patients with few treatment options.News Release June 29, 2021 Cell-based immunotherapy shows promise against melanomaEffective against blood cancers, natural killer cells also may be effective against solid tumors.News Release July 22, 2020 2 immunotherapies merged into single, more effective treatmentMouse study suggests strategy may work against variety of cancers.News Release May 10, 2018 4 medical students named Howard Hughes fellowsAward offers year of mentored research.News Release July 9, 2015 Four medical students selected as Howard Hughes fellowsStudents are among 68 nationwide selected for a year of mentored research training.Medical Campus & Community, School of Medicine, Video Posts navigation